| Outcome Measures: |
Primary: Change from Baseline in Homeostatic Model Assessment - Beta cell., Week: 24 or Final Visit beyond week 12. | Secondary: Change from Baseline in Glycosylated Hemoglobin., Week: 24 or Final Visit beyond week 12.|Change from Baseline in oral glucose tolerance testing., Week: 24 or Final Visit beyond week 12.|Change from Baseline in Insulin., Week: 24 or Final Visit beyond week 12.|Change from Baseline in Proinsulin., Week: 24 or Final Visit beyond week 12.|Change from Baseline in C-peptide., Week: 24 or Final Visit beyond week 12.|Change from Baseline in High sensitivity C-Reactive Protein., Week: 24 or Final Visit beyond week 12.|Change from Baseline in Adiponectin., Week: 24 or Final Visit beyond week 12.|Change from Baseline in Homeostatic Model Assessment - Sensitivity., Week: 24 or Final Visit beyond week 12.|Change from Baseline in Triglycerides, Week: 24 or Final Visit beyond week 12.|Change from Baseline in Low Density Lipoprotein-Cholesterol, Week: 24 or Final Visit beyond week 12.|Change from Baseline in High Density Lipoprotein-Cholesterol, Week: 24 or Final Visit beyond week 12.|Change from Baseline in Total Cholesterol, Week: 24 or Final Visit beyond week 12.
|
| Locations: |
Villingen-Schwenningen, Baden-Württemberg, Germany|Aschaffenburg, Bayern, Germany|Ingolstadt, Bayern, Germany|Frankfurt, Hessen, Germany|Frielendorf, Hessen, Germany|Rotenburg, Hessen, Germany|Hannover, Niedersachsen, Germany|Dortmund, Nordrhein-Westfalen, Germany|Siegen, Nordrhein-Westfalen, Germany|Kallstadt, Rheinland-Pfalz, Germany|Mainz, Rheinland-Pfalz, Germany|Mayen, Rheinland-Pfalz, Germany|Neuwied, Rheinland-Pfalz, Germany|Rhaunen, Rheinland-Pfalz, Germany|Friedrichsthal, Saarland, Germany|Meißen, Sachsen, Germany|Berlin, Germany
|
